← Holders
Remedium Capital Partners, LLC
What Remedium Capital Partners, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 2104501 · Filed Nov 13, 2026
- Positions
- 6
- Reported value
- $273.6M
- Opened
- 2
- Closed
- 2
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Dec 31, 2025$170.2K6 positions
- Mar 31, 2026$281.2M6 positions
- Jun 30, 2026$451.6M6 positions
- Sep 30, 2026$273.6M6 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
SYRESpyre Therapeutics, Inc. | 1.2M | −20.7% | $103.3M | 37.8% |
ORKAOruka Therapeutics, Inc. | 954.2K | −39.1% | $79.5M | 29% |
DMRADamora Therapeutics, Inc. | 2M | New | $43.5M | 15.9% |
JBIOJade Biosciences, Inc. | 1.8M | +14.6% | $25.4M | 9.3% |
KRSAKorsana Biosciences, Inc. | 518.5K | New | $16.6M | 6.1% |
CBIOCrescent Biopharma, Inc. | 361.3K | ±0% | $5.3M | 1.9% |